Kochhar, G. S., Desai, A., Farraye, F. A., Cross, R. K., El‐Hachem, S., Dulai, P. S., & Regueiro, M. (2023). Efficacy of biologic and small molecule agents as second‐line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity‐matched cohort study. Alimentary Pharmacology & Therapeutics, 58(3), 297. https://doi.org/10.1111/apt.17570
Chicago Style (17th ed.) CitationKochhar, Gursimran S., Aakash Desai, Francis A. Farraye, Raymond K. Cross, Sandra El‐Hachem, Parambir S. Dulai, and Miguel Regueiro. "Efficacy of Biologic and Small Molecule Agents as Second‐line Therapy After Exposure to TNF Inhibitors in Patients with Ulcerative Colitis: A Propensity‐matched Cohort Study." Alimentary Pharmacology & Therapeutics 58, no. 3 (2023): 297. https://doi.org/10.1111/apt.17570.
MLA (9th ed.) CitationKochhar, Gursimran S., et al. "Efficacy of Biologic and Small Molecule Agents as Second‐line Therapy After Exposure to TNF Inhibitors in Patients with Ulcerative Colitis: A Propensity‐matched Cohort Study." Alimentary Pharmacology & Therapeutics, vol. 58, no. 3, 2023, p. 297, https://doi.org/10.1111/apt.17570.